Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.
Demirci A, Alkış N, Dane F, Durnalı A, Yazıcı ÖK, Rzayev R, Kaya S, Yazılıtaş D, İnanç M, Özçelik M, Akman T, Kaplan MA, Günaydın Y, Ulaş A, Sönmez Ö, Tokluoğlu S, Gököz Doğu G, Bal Ö, Gümüş M. Demirci A, et al. Among authors: gunaydin y. Asia Pac J Clin Oncol. 2018 Apr;14(2):e145-e151. doi: 10.1111/ajco.12685. Epub 2017 Apr 21. Asia Pac J Clin Oncol. 2018. PMID: 28429422
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Demirci U, Tufan G, Aktas B, Balakan O, Alacacioglu A, Dane F, Engin H, Kaplan MA, Gunaydin Y, Ozdemir NY, Tugba Unek I, Karaca H, Akman T, Sonmez OU, Coskun U, Harputluoglu H, Sevinc A, Tonyali O, Buyukberber S, Benekli M. Demirci U, et al. Among authors: gunaydin y. J Cancer Res Clin Oncol. 2013 May;139(5):829-35. doi: 10.1007/s00432-013-1390-8. Epub 2013 Feb 12. J Cancer Res Clin Oncol. 2013. PMID: 23400732
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab.
Tonyali O, Coskun U, Sener N, Inanc M, Akman T, Ulas A, Yazilitas D, Bal O, Kucukoner M, Yildirim Ozdemir N, Demirci U, Gunaydin Y, Yildiz R, Karaca H, Umit Unal O, Gumus M, Benekli M, Buyukberber S. Tonyali O, et al. Among authors: gunaydin y. Onkologie. 2013;36(10):554-8. doi: 10.1159/000355156. Epub 2013 Sep 16. Onkologie. 2013. PMID: 24107908
Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncology.
Yetisyigit T, Arpaci E, Seber ES, Kucukoner M, Kos FT, Sonmez OU, Alici S, Akman T, Aktas B, Yildiz R, Gunaydin Y, Inanc M, Demirci U, Alkis N, Gumus M. Yetisyigit T, et al. Among authors: gunaydin y. Asian Pac J Cancer Prev. 2013;14(9):5185-8. doi: 10.7314/apjcp.2013.14.9.5185. Asian Pac J Cancer Prev. 2013. PMID: 24175798 Free article.
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.
Tonyali O, Coskun U, Yuksel S, Inanc M, Bal O, Akman T, Yazilitas D, Ulas A, Kucukoner M, Aksoy A, Demirci U, Uysal M, Tanriverdi O, Gunaydin Y, Sumbul AT, Yildiz R, Karaca H, Oksuzoglu B, Ciltas A, Buyukberber S, Benekli M; Anatolian Society of Medical Oncology (ASMO). Tonyali O, et al. Among authors: gunaydin y. Breast. 2016 Feb;25:22-6. doi: 10.1016/j.breast.2015.11.006. Epub 2015 Dec 20. Breast. 2016. PMID: 26801412
Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology).
Kaplan MA, Arslan UY, Işıkdogan A, Dane F, Oksuzoglu B, Inanc M, Akman T, Kucukoner M, Cinkir HY, Rzazade R, Ozkan M, Yilmaz U, Bayoglu IV, Gunaydin Y, Baykara M, Yazilitas D, Cubukcu E, Suner A, Ersoy U, Bilici M, Yazici O, Cayır K, Demirci U, Uysal M. Kaplan MA, et al. Among authors: gunaydin y. Breast Care (Basel). 2016 Aug;11(4):248-252. doi: 10.1159/000448186. Epub 2016 Aug 9. Breast Care (Basel). 2016. PMID: 27721711 Free PMC article.
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO).
Unal OU, Oztop I, Menekse S, Urakci Z, Bozkurt O, Ozcelik M, Gunaydin Y, Yasar N, Yazilitas D, Kodaz H, Taskoylu BY, Aksoy A, Demirci U, Araz M, Tonyali O, Sevinc A, Yilmaz AU, Benekli M. Unal OU, et al. Among authors: gunaydin y. Asian Pac J Cancer Prev. 2015;16(11):4777-80. doi: 10.7314/apjcp.2015.16.11.4777. Asian Pac J Cancer Prev. 2015. PMID: 26107239 Free article.
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology).
Inal A, Kodaz H, Odabas H, Duran AO, Seker MM, İnanc M, Elkıran ET, Gunaydın Y, Menekse S, Topcu TO, Urakcı Z, Tastekin D, Bilici M, Cihan S, Geredeli C, Sezer E, Uncu D, Arpacı E, Ozturk B, Bal O, Uysal M, Tanrıverdi O, Gumus M, Oven Ustaalioglu BB, Suner A, Cokmert S, Hacıbekiroglu İ, Aydın K, Isıkdogan A. Inal A, et al. Among authors: gunaydin y. J Cancer Res Ther. 2018 Apr-Jun;14(3):578-582. doi: 10.4103/0973-1482.176417. J Cancer Res Ther. 2018. PMID: 29893321 Free article.
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Unal OU, Oztop I, Yasar N, Urakci Z, Ozatli T, Bozkurt O, Sevinc A, Gunaydin Y, Yapar Taskoylu B, Arpaci E, Ulas A, Kodaz H, Tonyali O, Avci N, Aksoy A, Yilmaz AU. Unal OU, et al. Among authors: gunaydin y. Thorac Cancer. 2015 Jan;6(1):85-90. doi: 10.1111/1759-7714.12150. Epub 2015 Jan 7. Thorac Cancer. 2015. PMID: 26273340 Free PMC article.
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Sendur MA, Ozdemir N, Özatlı T, Yazıcı O, Aksoy S, Ekinci AS, Yazılıtaş D, Günaydın Y, Oksuzoglu B, Benekli M, Zengin N. Sendur MA, et al. Among authors: gunaydin y. Med Oncol. 2014 Sep;31(9):153. doi: 10.1007/s12032-014-0153-y. Epub 2014 Aug 7. Med Oncol. 2014. PMID: 25099765
89 results